Matches in Nanopublications for { ?s ?p "The potential link between Ang II and atherosclerosis is strengthened by the Heart Outcomes Prevention Evaluation (HOPE) trial where ACE (angiotensin converting enzyme) inhibition reduced the rates of death, myocardial infarction, and stroke in patients with atherosclerosis [57]." ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- _4 value "The potential link between Ang II and atherosclerosis is strengthened by the Heart Outcomes Prevention Evaluation (HOPE) trial where ACE (angiotensin converting enzyme) inhibition reduced the rates of death, myocardial infarction, and stroke in patients with atherosclerosis [57]." provenance.
- _4 value "The potential link between Ang II and atherosclerosis is strengthened by the Heart Outcomes Prevention Evaluation (HOPE) trial where ACE (angiotensin converting enzyme) inhibition reduced the rates of death, myocardial infarction, and stroke in patients with atherosclerosis [57]." provenance.
- _4 value "The potential link between Ang II and atherosclerosis is strengthened by the Heart Outcomes Prevention Evaluation (HOPE) trial where ACE (angiotensin converting enzyme) inhibition reduced the rates of death, myocardial infarction, and stroke in patients with atherosclerosis [57]." provenance.
- _4 value "The potential link between Ang II and atherosclerosis is strengthened by the Heart Outcomes Prevention Evaluation (HOPE) trial where ACE (angiotensin converting enzyme) inhibition reduced the rates of death, myocardial infarction, and stroke in patients with atherosclerosis [57]." provenance.